The next generation of weight-loss drugs

The Lancet Voice by The Lancet Group

It’s no exaggeration to say that the past decade has revolutionized how we think about and treat obesity. Drugs like semaglutide (Wegovy) and tirzepatide (Zepbound) have dominated headlines, enabling significant weight l...View more